Olivier Cuvillier

7PUBLICATIONS
14CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cell development, proliferation and deathPredictive and prognostic markersBiologically active moleculesNeurology and neuromuscular diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jan 21, 2023
N-Heterocyclic Carbene-Iridium Complexes as Photosensitizers for In Vitro Photodynamic Therapy to Trigger Non-Apoptotic Cell Death in Cancer Cells.

Xing Wang, Chen Zhang, Ryma Madji

|Apr 12, 2022
Sphingosine 1-Phosphate Receptor 5 (S1P5) Deficiency Promotes Proliferation and Immortalization of Mouse Embryonic Fibroblasts.

Franck Talmont, Elodie Mitri, Christine Dozier

|Feb 15, 2022
Sphingosine Kinase-1 Is Overexpressed and Correlates with Hypoxia in Osteosarcoma: Relationship with Clinicopathological Parameters.

Anne Gomez-Brouchet, Claire Illac, Adeline Ledoux

|Jul 15, 2020
Increased phospholipase D activity contributes to tumorigenesis in prostate cancer cell models.

Mathieu Borel, Olivier Cuvillier, David Magne

|Apr 19, 2020
An Artemisinin-Derivative-(NHC)Gold(I) Hybrid with Enhanced Cytotoxicity through Inhibition of NRF2 Transcriptional Activity.

Chen Zhang, Pierre-Yves Fortin, Guillaume Barnoin

|Apr 02, 2020
[Multiple sclerosis and immuno-modulators of sphingosine 1-phosphate receptors].

Franck Talmont, Anastassia Hatzoglou, Olivier Cuvillier

Pageof 2

Frequent Collaborators

2 joint publications

Anastassia Hatzoglou

2 joint publications

Heinz Gornitzka

2 joint publications

Franck Talmont

1 joint publications

Sophie Branka